ZimVie (ZIMV) Revenue & Revenue Breakdown
ZimVie Revenue Highlights
Latest Revenue (Y)
$449.75M
Latest Revenue (Q)
$103.22M
Main Segment (Y)
Segment Total
Main Geography (Y)
UNITED STATES
ZimVie Revenue by Period
ZimVie Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $449.75M | -1.68% |
| 2023-12-31 | $457.43M | -49.95% |
| 2022-12-31 | $913.86M | -9.93% |
| 2021-12-31 | $1.01B | 11.20% |
| 2020-12-31 | $912.40M | -13.56% |
| 2019-12-31 | $1.06B | -3.97% |
| 2018-12-31 | $1.10B | - |
ZimVie generated $449.75M in revenue during NA 2024, up -1.68% compared to the previous quarter, and up 42.61% compared to the same period a year ago.
ZimVie Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $103.22M | -11.63% |
| 2024-06-30 | $116.81M | -1.17% |
| 2024-03-31 | $118.19M | 4.54% |
| 2023-12-31 | $113.07M | -44.27% |
| 2023-09-30 | $202.87M | -9.79% |
| 2023-06-30 | $224.90M | -0.24% |
| 2023-03-31 | $225.43M | -1.61% |
| 2022-12-31 | $229.12M | 6.78% |
| 2022-09-30 | $214.58M | -8.52% |
| 2022-06-30 | $234.56M | -0.44% |
| 2022-03-31 | $235.60M | -9.94% |
| 2021-12-31 | $261.60M | 9.17% |
| 2021-09-30 | $239.62M | -9.82% |
| 2021-06-30 | $265.73M | 7.26% |
| 2021-03-31 | $247.73M | -9.88% |
| 2020-12-31 | $274.90M | - |
ZimVie generated $103.22M in revenue during Q3 2024, up -11.63% compared to the previous quarter, and up 45.90% compared to the same period a year ago.
ZimVie Revenue Breakdown
ZimVie Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Segment Total | $909.49M | $1.01B |
| Dental | $459.68M | $468.50M |
| Spine | $449.81M | $540.30M |
ZimVie's latest annual revenue breakdown by segment (product or service), as of Dec 22: Segment Total (50.00%), Dental (25.27%), and Spine (24.73%).
Quarterly Revenue by Product
| Product/Service | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|
| Spine | $97.56M | $106.25M | $104.92M | $112.32M | $108.15M | $115.22M | $114.11M |
| Dental | $105.31M | $118.65M | $120.17M | $115.84M | $105.12M | $118.15M | $120.57M |
| Segment Total | $202.87M | $224.90M | $225.09M | $228.16M | $213.27M | $233.37M | $234.68M |
ZimVie's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Segment Total (50.00%), Dental (25.96%), and Spine (24.04%).
ZimVie Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|
| UNITED STATES | $266.82M | $630.14M | $675.60M |
| SPAIN | $50.03M | - | - |
| Other Countries | $132.90M | $279.35M | - |
ZimVie's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (59.33%), Other Countries (29.55%), and SPAIN (11.12%).
Quarterly Revenue by Country
| Country | Dec 24 | Sep 24 | Jun 24 | Mar 24 |
|---|---|---|---|---|
| UNITED STATES | $64.40M | $65.35M | $69.32M | $67.75M |
| SPAIN | $12.78M | $9.09M | $12.82M | $15.35M |
| Other Countries | $34.34M | $28.78M | $34.67M | $35.10M |
ZimVie's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (57.75%), Other Countries (30.80%), and SPAIN (11.46%).
ZimVie Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SYK | Stryker | $22.59B | $5.49B |
| BSX | Boston Scientific | $16.75B | $3.39B |
| SNN | Smith & Nephew | $5.55B | $2.79B |
| STE | STERIS | $5.14B | $1.37B |
| CNMD | CONMED | $1.31B | $316.70M |
| ZIMV | ZimVie | $449.75M | $103.22M |
| AORT | Artivion | $388.54M | $95.78M |
| INGN | Inogen | $335.70M | $88.83M |
| KIDS | OrthoPediatrics | $204.73M | $52.80M |
| SIBN | SI-BONE | $167.18M | $40.34M |
| SRDX | Surmodics | $126.08M | $29.92M |
| LUNG | Pulmonx | $83.79M | $20.39M |
| NPCE | NeuroPace | $79.91M | $21.06M |
| SGHT | Sight Sciences | $79.87M | $20.16M |
| CVRX | CVRx | $51.29M | $13.37M |
| APYX | Apyx Medical | $48.10M | $16.02M |
| OFIX | Orthofix Medical | - | $198.62M |